FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Canada Approves DermTech Pigmented Lesions Assay

Jan. 8, 2018
A A

California-based manufacturer of molecular dermatology DermTech secured approval to market its Pigmented Lesions Assay and its biopsy kit for detecting melanoma in Canada.

DermTech Canada will market and sell the assay in the country, and biopsy samples will be processed at the company’s central laboratory in La Jolla.

The assay is designed to analyze skin biopsy samples through a noninvasive adhesive patch.

View today's stories